1-2 of 2
Gabriel De Avila
Close
Sort by
Journal Articles

Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy

Clinical Trials & Observations
Lauren C. Peres, Laura B. Oswald, Christen M. Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J. Blue, Ciara L. Freeman, Frederick L. Locke, Melissa Alsina, Omar Castaneda Puglianini, Leyla Shune, Douglas W. Sborov, Charlotte Wagner, Danai Dima, Hamza Hashmi, James A. Davis, Mehmet H. Kocoglu, Ashraf Z. Badros, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher Ferreri, Larry D. Anderson, Jr, Aimaz Afrough, Gurbakhash Kaur, Yi Lin, Lawrence Liu, Omar Nadeem, Peter Voorhees, Jack Khouri, Joseph McGuirk, Surbhi Sidana, Doris K. Hansen, Krina Patel
Journal: Blood Advances
Blood Adv (2024) 8 (1): 251–259.
https://doi.org/10.1182/bloodadvances.2023010894
Published: 2024
Includes: Supplemental data
Journal Articles

IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB– and caspase-8–dependent mechanisms

Liang Zhou, Yu Zhang, Mark B. Meads, Yun Dai, Yanxia Ning, Xiaoyan Hu, Lin Li, Kanika Sharma, Jewel Nkwocha, Rebecca Parker, Danny Bui, Jacquelyn McCarter, Lora Kramer, Cullen Purcell, Praneeth R. Sudalagunta, Rafael R. Canevarolo, Maria D. Coelho Siqueira Silva, Gabriel De Avila, Raghunandan Reddy Alugubelli, Ariosto S. Silva, Maciej Kmeiciak, Andrea Ferreira-Gonzalez, Kenneth H. Shain, Steven Grant
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3776–3788.
https://doi.org/10.1182/bloodadvances.2020003597
Published: 2021
Includes: Supplemental data